Schedule 13D ownership disclosure
CHEMOMAB THERAPEUTICS LTD
Security class unavailable · CUSIP: 16385C104
Event date: 2024-09-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-24-000757
- Form type
- SC 13D
- Filer
- Chemomab Therapeutics Ltd.
- CIK
- CIK 1534248
- Filed
- Sep 16, 2024
- Reporting period
- Sep 12, 2024
- Description
- Schedule 13D beneficial ownership